These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 228169)
1. Interferon and its therapeutic potential. Ho M Med J Aust; 1979 Jul; 2(1):11-2. PubMed ID: 228169 [No Abstract] [Full Text] [Related]
2. Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections. Hayden FG Antiviral Res; 1985; Suppl 1():229-39. PubMed ID: 2417551 [TBL] [Abstract][Full Text] [Related]
3. Recent trends and development in antiviral chemotherapy. De Clercq E Antiviral Res; 1985; Suppl 1():11-9. PubMed ID: 2417547 [No Abstract] [Full Text] [Related]
5. Effect of bovine fibroblast interferon on rhinovirus infection in calves. Rosenquist BD; Allen GK Am J Vet Res; 1990 Jun; 51(6):870-3. PubMed ID: 1695067 [TBL] [Abstract][Full Text] [Related]
6. Interferon therapy. Williams CN Can J Gastroenterol; 1997 Oct; 11(7):563-4. PubMed ID: 9395755 [No Abstract] [Full Text] [Related]
7. Significance of the interferon (IFN) in the therapy. Mahmutović S; Beslagić E Bosn J Basic Med Sci; 2004 Oct; 4(4):42-4. PubMed ID: 15628995 [TBL] [Abstract][Full Text] [Related]
8. Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections. Rawlinson WD Med J Aust; 2001 Jul; 175(2):112-6. PubMed ID: 11556411 [TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy for enteroviruses and rhinoviruses. Rotbart HA Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388 [TBL] [Abstract][Full Text] [Related]
10. Exogenous interferon in animals and its clinical implications. Finter NB Arch Intern Med; 1970 Jul; 126(1):147-57. PubMed ID: 4987552 [No Abstract] [Full Text] [Related]
11. Current leads in antiviral chemotherapy. De Clercq E J Antimicrob Chemother; 1986 Apr; 17(4):399-402. PubMed ID: 3011723 [No Abstract] [Full Text] [Related]
12. Antiviral agents: the road from scepticism to efficacy. Galasso GJ Acta Microbiol Acad Sci Hung; 1981; 28(3):313-24. PubMed ID: 6171143 [No Abstract] [Full Text] [Related]
13. Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and humans. Johnson PE; Greenberg SB; Harmon MW; Alford BR; Couch RB J Clin Microbiol; 1976 Jul; 4(1):106-7. PubMed ID: 182714 [TBL] [Abstract][Full Text] [Related]
15. IFN-lambda therapy: current status and future perspectives. Lasfar A; Zloza A; Cohen-Solal KA Drug Discov Today; 2016 Jan; 21(1):167-171. PubMed ID: 26552337 [TBL] [Abstract][Full Text] [Related]
16. Could preventive intranasal interferon lower the morbidity in children prone to respiratory illness? Douglas RM; Moore B; Miles HB; Pinnock CB Med J Aust; 1990 May; 152(10):524, 527-8. PubMed ID: 1692602 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of respiratory virus infection by locally applied interferon. Merigan TC; Reed SE; Hall TS; Tyrrell DA Lancet; 1973 Mar; 1(7803):563-7. PubMed ID: 4120640 [No Abstract] [Full Text] [Related]
18. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. Pollard RB Drugs; 1982; 23(1-2):37-55. PubMed ID: 6173188 [No Abstract] [Full Text] [Related]
19. Transcriptomic Analysis Reveals Priming of The Host Antiviral Interferon Signaling Pathway by Bronchobini Reamon-Buettner SM; Niehof M; Hirth N; Danov O; Obernolte H; Braun A; Warnecke J; Sewald K; Wronski S Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067687 [TBL] [Abstract][Full Text] [Related]
20. Update on therapy of influenza and rhinovirus infections. Arruda E; Hayden FG Adv Exp Med Biol; 1996; 394():175-87. PubMed ID: 8815685 [No Abstract] [Full Text] [Related] [Next] [New Search]